Tag: BioLife4D

BIOLIFE4D Becomes First U.S. Company to Successfully Demonstrate Ability to 3D Bioprint a Mini Human Heart

Pioneering biotech company reaches significant milestone, using proprietary bioink to successfully 3D bioprint a mini-heart with full structure of a whole heart, including chambers and ventricles CHICAGO, Sept. 09, 2019 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today […]

BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue

CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully demonstrated its ability to 3D bioprint human cardiac tissue – specifically, a human cardiac patch. The scientific milestone was accomplished within days […]

BIOLIFE4D Appoints Texas Heart Institute Surgeon Dr. Jeffrey Morgan Chief Medical Officer, Bolstering Leadership Team

CHICAGO, Oct. 13, 2017 /PRNewswire/ — Bioprinting startup BIOLIFE4D named accomplished thoracic and cardiac surgeon Jeffrey Morgan M.D., FACS, FACC as Chief Medical Officer, further bolstering its world-class leadership team. BIOLIFE4D is a pioneering biotech company focused on leveraging advances in life sciences and tissue engineering to 3D bioprint a viable human heart suitable for transplant. Joining […]

Biotech Pioneer BIOLIFE4D Submits Regulation A+ Filing with SEC for up to $50 Million Initial Public Offering

CHICAGO, Sept. 7, 2017 /PRNewswire/ — BIOLIFE4D announced it filed a $50 million initial public offering with the Securities and Exchange Commission (SEC) under Regulation A+ rules, allowing everyday investors to help the company bring its groundbreaking cardiac tissue regeneration and organ replacement process to market. Chicago-based BIOLIFE4D is a pioneering biotech company focused on leveraging […]